Increased sensitivity of SARS-coronavirus to a combination of human type I and type II interferons

Antivir Ther. 2004 Dec;9(6):1003-11.

Abstract

There is currently an urgent need to identify effective antiviral agents that will prevent and treat severe acute respiratory syndrome coronavirus (SARS-CoV) infection. In this study, we have investigated and compared the antiviral effect of different interferons (IFNs) on SARS-CoV replication in the epithelial kidney monkey Vero cell line. The results showed that SARS-CoV grown in Vero cells is moderately sensitive to IFN-beta and only weakly sensitive to IFN-alpha and IFN-gamma, in comparison to other IFN-sensitive viruses, such as those for encephalomyocarditis, vesicular stomatitis and Newcastle disease. Simultaneous incubation of Vero cells with IFN-beta and IFN-gamma indicated that they may act synergistically against SARS-CoV replication. The IFN-induced MxA protein was detected in the IFN-treated Vero cells. The data, however, suggest that the antiviral activity of IFN against SARS-CoV virus is independent of MxA expression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Chlorocebus aethiops
  • Drug Synergism
  • GTP-Binding Proteins / genetics
  • GTP-Binding Proteins / metabolism
  • Humans
  • Interferon Type I / genetics
  • Interferon Type I / pharmacology*
  • Interferon-gamma / genetics
  • Interferon-gamma / pharmacology*
  • Myxovirus Resistance Proteins
  • Recombinant Proteins / pharmacology
  • Severe acute respiratory syndrome-related coronavirus / drug effects*
  • Severe acute respiratory syndrome-related coronavirus / physiology
  • Vero Cells
  • Virus Replication / drug effects*

Substances

  • Interferon Type I
  • MX1 protein, human
  • Myxovirus Resistance Proteins
  • Recombinant Proteins
  • Interferon-gamma
  • GTP-Binding Proteins